Multiple Sclerosis: Neurorehabilitation and Symptomatic Treatment

被引:1
作者
Sailer, Michael [1 ,2 ,3 ]
Lindquist, Sabine [4 ,5 ]
Sickert, Almut [5 ]
Lamprecht, Juliane [3 ,5 ]
机构
[1] MEDIAN Kliniken, Neurol Rehabil Zentrum, Magdeburg, Germany
[2] MEDIAN Kliniken, Neurol Rehabil Zentrum, Flechtingen, Germany
[3] Otto Von Guericke Univ, Inst Neurorehabil, Magdeburg, Germany
[4] Pfeiffersche Stiftungen Magdeburg, Med Zentrums Erwachsene Behinderung, Magdeburg, Germany
[5] MEDIAN Klin, Neurol Rehabil Zentrum, Magdeburg, Germany
关键词
multiple sclerosis; inpatient rehabilitation; neurorehabilitation; DISEASE; DIAGNOSIS;
D O I
10.1055/a-0755-1398
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Multiple sclerosis is the most common cause of non-traumatic disability in young adults. The following article addresses special features of multiple sclerosis in the context of neurological rehabilitation. The rehabilitative and symptomatic therapy of frequent symptoms and functional deficits are presented independently of the course of the disease. Rehabilitation in MS focuses on functional deficits in mobility, paresis, spasticity, ataxia, bladder dysfunction, fatigue, cognitive symptoms, depression and pain. The multimodal inpatient rehabilitation comprises aerobic training in MS- specific groups and interventions targeting individual deficits. Neuropsychological training, individual and group session on coping and adherence to therapy as well as advice on social issues and the evaluation of the work place situation complement the therapy options. The early age of onset of the disease often causes an early restriction of participation in working life. The restoration and maintenance of work ability is therefore an essential goal of neurological rehabilitation, as well as the organization of aftercare and the introduction of vocational rehabilitation services.
引用
收藏
页码:339 / 350
页数:12
相关论文
共 21 条
[1]  
[Anonymous], 1998, Multiple sclerosis council for clinical pradice guidelines. Fatigue and multiple sclerosis: evidence based management strategies for fatigue in multiple sclerosis
[2]   Rehabilitation interventions in multiple sclerosis: an overview [J].
Beer, Serafin ;
Khan, Fary ;
Kesselring, Juerg .
JOURNAL OF NEUROLOGY, 2012, 259 (09) :1994-2008
[3]   Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis [J].
Brown, J. William L. ;
Coles, Alasdair ;
Horakova, Dana ;
Havrdova, Eva ;
Izquierdo, Guillermo ;
Prat, Alexandre ;
Girard, Marc ;
Duquette, Pierre ;
Trojano, Maria ;
Lugaresi, Alessandra ;
Bergamaschi, Roberto ;
Grammond, Pierre ;
Alroughani, Raed ;
Hupperts, Raymond ;
McCombe, Pamela ;
Van Pesch, Vincent ;
Sola, Patrizia ;
Ferraro, Diana ;
Grand'Maison, Francois ;
Terzi, Murat ;
Lechner-Scott, Jeannette ;
Flechter, Schlomo ;
Slee, Mark ;
Shaygannejad, Vahid ;
Pucci, Eugenio ;
Granella, Franco ;
Jokubaitis, Vilija ;
Willis, Mark ;
Rice, Claire ;
Scolding, Neil ;
Wilkins, Alastair ;
Pearson, Owen R. ;
Ziemssen, Tjalf ;
Hutchinson, Michael ;
Harding, Katharine ;
Jones, Joanne ;
McGuigan, Christopher ;
Butzkueven, Helmut ;
Kalincik, Tomas ;
Robertson, Neil ;
Onofrj, Marco ;
De Luca, Giovanna ;
Di Tommaso, Valeria ;
Travaglini, Daniela ;
Pietrolongo, Erika ;
di Ioia, Maria ;
Farina, Deborah ;
Mancinelli, Luca ;
Hodgkinson, Suzanne ;
Oreja-Guevara, Celia .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (02) :175-187
[4]  
Deutsche Gesellschaft fur Multiple Sklerose, 2009, MS DEUTSCHL
[5]   Multiple Sclerosis Registry in Germany Results of the Extension Phase 2005/2006 [J].
Flachenecker, P. ;
Stuke, K. ;
Elias, W. ;
Freidel, M. ;
Haas, J. ;
Pitschnau-Michel, D. ;
Schimrigk, S. ;
Zettl, U. K. ;
Rieckmann, P. .
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2008, 105 (07) :113-119
[6]  
Giovannoni G, 2012, ACNR, V12, P8
[7]   New aspects of symptomatic MS treatment: Part 5-fatigue [J].
Henze, T. ;
Feneberg, W. ;
Flachenecker, P. ;
Seidel, D. ;
Albrecht, H. ;
Starck, M. ;
Meuth, S. G. .
NERVENARZT, 2018, 89 (04) :446-452
[8]   New aspects of symptomatic MS treatment: Part 6-cognitive dysfunction and rehabilitation [J].
Henze, T. ;
Feneberg, W. ;
Flachenecker, P. ;
Seidel, D. ;
Albrecht, H. ;
Starck, M. ;
Meuth, S. G. .
NERVENARZT, 2018, 89 (04) :453-459
[9]  
Henze T, 2018, NERVENARZT, V89, P184, DOI 10.1007/s00115-017-0440-x
[10]   What is new in symptomatic MS treatment: Part 2-gait disorder and spasticity [J].
Henze, T. ;
Feneberg, W. ;
Flachenecker, P. ;
Seidel, D. ;
Albrecht, H. ;
Starck, M. ;
Meuth, S. G. .
NERVENARZT, 2017, 88 (12) :1428-1434